Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login

Markets:

Overview

News

Currencies

International

Treasuries

Sunshine Biopharma Inc. - Common stock (NQ:SBFM)

3.000 +0.040 (+1.35%)

Delayed Quote Updated: 1:14 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sunshine Biopharma Inc. - Common stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Mid-Afternoon Market Update: Nasdaq Rises 70 Points; Eliem Therapeutics Shares Slide ↗

April 25, 2022

U.S. stocks pared losses toward the end of trading, with the Nasdaq Composite gaining around 70 points on Monday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 25, 2022

Via Benzinga

Why Is Sunshine Biopharma (SBFM) Stock Up Today? ↗

April 25, 2022

Today, investors in Sunshine Biopharma and SBFM stock are getting a huge boost from news that the company filed a patent for a key drug.

Via InvestorPlace

Mid-Day Market Update: Crude Oil Tumbles Over 6%; Nkarta Shares Spike Higher ↗

April 25, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 400 points on Monday.

Via Benzinga

34 Stocks Moving In Monday's Mid-Day Session ↗

April 25, 2022

Gainers Nkarta, Inc. (NASDAQ: NKTX) shares jumped 108.6% to $16.21 after the company announced Phase 1 data from independent dose finding studies of its two lead chimeric antigen...

Via Benzinga

Why Sunshine Biopharma Stock Is Surging ↗

April 25, 2022

Sunshine Biopharma Inc (NASDAQ: SBFM) shares are trading higher Monday after the company announced it filed a United States provisional patent application covering the...

Via Benzinga

Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multidrug Resistant Cancer Cells ↗

April 25, 2022

Montreal, Quebec, Canada – (GLOBE NEWSWIRE) – Sunshine Biopharma, Inc.

Via Benzinga

Mid-Morning Market Update: Markets Open Lower; Dow Tumbles Over 300 Points ↗

April 25, 2022

U.S. stocks opened lower this morning, with the Dow Jones dropping more than 300 points on Monday.

Via Benzinga

Advanced Immunological and Clinical Trials for Treating Ovarian Cancer Accelerating

April 25, 2022

Palm Beach, FL – April 25, 2022 – FinancialNewsMedia.com News Commentary – The formation of mutational cells or tissues in female reproductive organs called ovaries leads to ovarian cancer. Cancer...

Via FinancialNewsMedia

Topics Intellectual Property

54 Biggest Movers From Yesterday ↗

April 20, 2022

Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) shares jumped 325.9% to close at $10.35 on Tuesday after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to...

Via Benzinga

Blockbuster Clinical Results Shine a Positive Light on Sunshine Biopharma ↗

April 19, 2022

An SEC filing may have deterred some traders from holding SBFM stock. However, a closer look at the facts should clear up any confusion.

Via InvestorPlace

5 Stocks Halted In Tuesday's Session ↗

April 19, 2022

A circuit breaker is an automatic, temporary trading halt on specific securities when the underlying stock is experiencing times of high volatility. It is a measure to help restore and bring order to...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 19, 2022

Gainers Checkmate Pharmaceuticals (NASDAQ:CMPI) stock increased by 331.9% to $10.41 during Tuesday's regular session. Trading volume for Checkmate Pharmaceuticals'...

Via Benzinga

EXCLUSIVE: Sunshine Biopharma Looks Ahead In COVID And Cancer Treatments ↗

April 19, 2022

Sunshine Biopharma Inc. (NASDAQ: SBFM) might be living the concept of being in the right place at the right time.

Via Benzinga

38 Stocks Moving In Tuesday's Mid-Day Session ↗

April 19, 2022

Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) climbed 329.2% to $10.43 after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to acquire the company for $...

Via Benzinga

68 Biggest Movers From Yesterday ↗

April 19, 2022

Gainers Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core...

Via Benzinga

Biotech Stocks News: What’s Going on With LIXT, PTE, QLGN and ATNM Stocks Today? ↗

April 12, 2022

Biotech stocks are up today amid an influx of positive news. Here's what investors need to know as these small companies skyrocket.

Via InvestorPlace

51 Biggest Movers From Thursday ↗

April 18, 2022

Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 69.4% to close at $2.44 on Thursday. Ally Bridge Group recently reported a purchase of 21.176 million shares of...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

April 12, 2022

Good morning! It's time for another dive into the market this morning with a look at the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

Mid-Afternoon Market Update: Nasdaq Falls 150 Points; Crude Oil Rises 2% ↗

April 08, 2022

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping more than 100 points on Friday.

Via Benzinga

Why Is Sunshine Biopharma (SBFM) Stock Down 30% Today? ↗

April 08, 2022

Sunshine Biopharma's winning streak is likely finished due to confusion over an announcement. Here's why SBFM stock is down today.

Via InvestorPlace

28 Stocks Moving In Friday's Mid-Day Session ↗

April 08, 2022

Gainers Lyra Therapeutics, Inc. (NASDAQ: LYRA) shares climbed 33.3% to $5.78 as the company reported a private placement for gross proceeds of $110.5 million. TSR, Inc. (NASDAQ...

Via Benzinga

Mid-Day Market Update: Dow Jumps Over 200 Points; Sunshine Biopharma Shares Slide ↗

April 08, 2022

U.S. stocks traded mixed midway through trading, with the Dow Jones surging more than 200 points on Friday.

Via Benzinga

Mid-Morning Market Update: Markets Edge Lower; US Wholesale Inventories Rise 2.5% In February ↗

April 08, 2022

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping 100 points on Friday.

Via Benzinga

Benzinga's Daily Brief On Trending Tickers For April 8, 2022: SoFi, Tesla, Taiwan Semiconductors And More ↗

April 08, 2022

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news...

Via Benzinga

Why Sunshine Biopharma Stock Is Falling Today ↗

April 08, 2022

Sunshine Biopharma Inc (NASDAQ: SBFM) shares are trading lower Friday morning after the company announced a common stock offering. Sunshine Biopharma plans to offer...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

April 08, 2022

Good morning, trader! Get ready for another busy day of trading with our breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

16 Stocks Moving in Friday's Pre-Market Session ↗

April 08, 2022

Gainers Biofrontera Inc. (NASDAQ: BFRI) rose 34.5% to $5.44 in pre-market trading. ENDRA Life Sciences Inc. (NASDAQ: NDRA) rose 31.9% to $0.5891 in pre-market trading after...

Via Benzinga

53 Biggest Movers From Yesterday ↗

April 08, 2022

Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 64.4% to close at $1.41 on Thursday. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 07, 2022

Gainers Trevi Therapeutics (NASDAQ:TRVI) stock rose 45.8% to $2.77 during Thursday's regular session. Trevi Therapeutics's stock is trading at a volume of 15.2...

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Free News Feed

Get our RSS Feed!

Home
Member's Home
Premium Content

Links
Entities
About StreetInsider
Get Our Content

Advertise with Us
Contact Us
Disclaimer
Privacy Policy